Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy
Trial details
- Registry ID
- NCT07209332
- Drugs studied
- WVE-N531
TrialRedline tracks 1 clinical trial sponsored by Wave Life Sciences USA, Inc.: 1 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular DystrophyNCT07209332 | WVE-N531 | Enrolling by invitation | 2029-03Estimated |
Names as written in the registry records.
NCT07209332 · Wave Life Sciences USA, Inc.
Before: Not yet recruiting. After: Enrolling by invitation.